Are H2 receptor antagonists safe over the counter drugs?
作者信息
Andersen M, Schou J S
出版信息
BMJ. 1994;309(6953):493-4. doi: 10.1136/bmj.309.6953.493.
Abstract
摘要
相似文献
1
Are H2 receptor antagonists safe over the counter drugs?H2受体拮抗剂是非处方药吗？它们安全吗？
BMJ. 1994;309(6953):493-4. doi: 10.1136/bmj.309.6953.493.
2
[Adverse effects of ulcer drugs before and after release of cimetidine, ranitidine and sucralfate for over-the-counter sale].[西咪替丁、雷尼替丁和硫糖铝非处方药上市前后溃疡药物的不良反应]
Ugeskr Laeger. 1991 May 13;153(20):1410-3.
3
Monitoring the safety of over the counter drugs.监测非处方药的安全性。
Br Med J (Clin Res Ed). 1987 Nov 28;295(6610):1414. doi: 10.1136/bmj.295.6610.1414-b.
4
Monitoring safety of over the counter drugs. Over the counter medicines must be treated like all other medicines.
BMJ. 2002 Feb 16;324(7334):424-5.
5
Monitoring safety of over the counter drugs. Patients could do more than just treat themselves.监测非处方药的安全性。患者能做的不止是自我治疗。
BMJ. 2002 Feb 16;324(7334):424-5.
6
Over-the-counter product line extensions: have we reached the limit yet?
J Am Geriatr Soc. 2004 Jul;52(7):1223-4. doi: 10.1111/j.1532-5415.2004.52327_9.x.
7
Bradycardia and H2 antagonists.心动过缓和H2拮抗剂。
Ann Intern Med. 1988 Sep 1;109(5):434-5. doi: 10.7326/0003-4819-109-5-434.
8
9
Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.H2受体拮抗剂对灌注大鼠肝脏中吲哚菁绿和利多卡因稳态摄取的影响。
J Lab Clin Med. 1986 Feb;107(2):112-7.
10
Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up.西咪替丁安全性的上市后监测：随访第二、三、四年期间的死亡率
Br Med J (Clin Res Ed). 1985 Oct 19;291(6502):1084-8. doi: 10.1136/bmj.291.6502.1084.
引用本文的文献
1
A survey on the incidence of common musculoskeletal side effects among the patients taking long-term anti-ulcerant therapies in Bangladesh.孟加拉国长期接受抗溃疡治疗患者常见肌肉骨骼副作用发生率的调查。
Toxicol Rep. 2022 Sep 17;9:1796-1805. doi: 10.1016/j.toxrep.2022.09.007. eCollection 2022.
2
Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: COX-2 inhibitors were thought of as a safe option.COX-2抑制剂和非甾体抗炎药引起胃肠道不良反应的风险：COX-2抑制剂曾被认为是一种安全的选择。
BMJ. 2005 Dec 17;331(7530):1474. doi: 10.1136/bmj.331.7530.1474-b.
3
General practitioners' views on the over-the-counter availability of H2-antagonists.全科医生对H2拮抗剂非处方可得性的看法。
Br J Gen Pract. 1997 Feb;47(415):99-102.
4
Patients, society, and the increase in self medication.患者、社会与自我药疗的增加。
BMJ. 1996 Mar 9;312(7031):629-32. doi: 10.1136/bmj.312.7031.629.
5
6
Over the counter H2 receptor antagonists. Increase the risks to offshore workers.非处方H2受体拮抗剂。增加近海作业工人的风险。
BMJ. 1994 Oct 29;309(6962):1156-7.
7
Over the counter H2 receptor antagonists. Serve only as expensive antacids.非处方H2受体拮抗剂。仅用作昂贵的抗酸剂。
BMJ. 1994 Oct 29;309(6962):1156. doi: 10.1136/bmj.309.6962.1156a.
本文引用的文献
1
Treatment of peptic ulcers caused by Helicobacter pylori.幽门螺杆菌引起的消化性溃疡的治疗。
N Engl J Med. 1993 Feb 4;328(5):349-50. doi: 10.1056/NEJM199302043280512.
2
Drugs: from prescription only to pharmacy only.
BMJ. 1993 Sep 11;307(6905):640. doi: 10.1136/bmj.307.6905.640.
3
Safety implications of the over-the-counter availability of H2-antagonists.H2拮抗剂非处方可得的安全性影响。
Drug Saf. 1993 Mar;8(3):179-85. doi: 10.2165/00002018-199308030-00001.
4
Over-the-counter histamine H2-receptor antagonists. How will they affect the treatment of acid-related diseases?非处方组胺H2受体拮抗剂。它们将如何影响酸相关性疾病的治疗？
Drugs. 1994 Jan;47(1):1-11. doi: 10.2165/00003495-199447010-00001.
5
The risks and benefits of an Rx-to-OTC switch. The case of over-the-counter H2-blockers.处方药转换为非处方药的风险与益处。以非处方H2阻滞剂为例。
Med Care. 1990 Sep;28(9):834-52. doi: 10.1097/00005650-199009000-00012.
6
Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status.西咪替丁和雷尼替丁转为非处方药状态前后丹麦对H2受体拮抗剂的不良反应。
Pharmacol Toxicol. 1991 Oct;69(4):253-8. doi: 10.1111/bcpt.1991.69.4.253.
Zotero 插件